Facebook pixel

Research Scientist
Protein Engineering, Mammalian Expression Libraries
Confirmed live in the last 24 hours
Vancouver, BC, Canada
Experience Level
Desired Skills
Data Analysis
  • Working with our cross-functional team on developing and implementing mammalian library screening approaches to engineer antibodies and protein antigens for therapeutic development purposes
  • Contributing hands-on to multiple aspects of screening, including library design and delivery, assay development and implementation, data analysis and interpretation
  • Organizing, supporting and collaborating with other team members to meet project deliverables and timelines
  • Training and mentoring more junior scientists
  • Preparing and authoring materials to educate colleagues, and communicate strategies, key findings and implications
  • You thrive in a collaborative environment
  • You are strongly self-motivated and work independently to identify project needs and follow that up with building and implementing solutions
  • You enjoy mentoring and bringing out the best in your teammates
  • You enjoy working in a fast-paced work environment and coordinating with your team to juggle multiple competing priorities
  • Post-doc or PhD in a relevant field, or MSc plus at least 5 years work experience in relevant field
  • Strong interpersonal skills with the ability to work collaboratively as a member of cross-functional team
  • Excellent verbal and written communication skills, including public presentation of complex data
  • Excellent documentation and organizational skills
Desired Qualifications
  • Experience with mammalian cell line engineering, and cell-based assay development (in-depth knowledge of flow cytometry applications or single cell technologies is a plus)
  • Familiarity with next-gen sequencing and library-based methods for protein engineering (experience with developing and screening mammalian libraries is a plus )
AbCellera Biologics
Company Overview
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.